187 related articles for article (PubMed ID: 30123968)
1. Cutaneous adverse drug reaction after apomorphine infusion, possibly caused by a systemic type IV hypersensitivity reaction to sodium metabisulfite: Report of 2 cases.
Borgemeester RWK; van Laar T; Schuttelaar MLA
Contact Dermatitis; 2018 Nov; 79(5):316-318. PubMed ID: 30123968
[No Abstract] [Full Text] [Related]
2. An unusual case of a systemic delayed hypersensitivity reaction to sodium metabisulfite.
Guha-Niyogi B; Sabroe R; Holden C
Contact Dermatitis; 2018 Oct; 79(4):246-247. PubMed ID: 29923202
[No Abstract] [Full Text] [Related]
3. [Continuous subcutaneous infusion of apomorphine in Parkinson's disease: retrospective analysis of a series of 81 patients].
Rambour M; Moreau C; Salleron J; Devos D; Kreisler A; Mutez E; Simonin C; Annic A; Dujardin K; Destée A; Defebvre L
Rev Neurol (Paris); 2014 Mar; 170(3):205-15. PubMed ID: 24594365
[TBL] [Abstract][Full Text] [Related]
4. [Treatment of apomorphine infusion adverse effects: subcutaneous nodules and neuropsychiatric complications].
Giménez de Béjar V; Carballo-Cordero M
Rev Neurol; 2012; 55 Suppl 1():S25-9. PubMed ID: 23169230
[TBL] [Abstract][Full Text] [Related]
5. Apomorphine-induced eosinophilic panniculitis and hypereosinophilia in Parkinson disease.
Pot C; Oppliger R; Castillo V; Coeytaux A; Hauser C; Burkhard PR
Neurology; 2005 Jan; 64(2):392-3. PubMed ID: 15668455
[No Abstract] [Full Text] [Related]
6. Allergic reactions to local anesthetic formulations.
Speca SJ; Boynes SG; Cuddy MA
Dent Clin North Am; 2010 Oct; 54(4):655-64. PubMed ID: 20831929
[TBL] [Abstract][Full Text] [Related]
7. Type IV hypersensitivity to sodium metabisulfite in local anaesthetic.
Riemersma WA; Schuttelaar ML; Coenraads PJ
Contact Dermatitis; 2004 Sep; 51(3):148. PubMed ID: 15479205
[No Abstract] [Full Text] [Related]
8. Subcutaneous infusions of apomorphine: a reappraisal of its therapeutic efficacy in advanced Parkinson's disease.
Grandas F
Expert Rev Neurother; 2013 Dec; 13(12):1343-53. PubMed ID: 24160681
[TBL] [Abstract][Full Text] [Related]
9. Immediate type 1 hypersensitivity to apomorphine: a case report.
Gutiérrez D; Foncubierta A; Espinosa R; Astorga S; Leon A; Fernández S
J Investig Allergol Clin Immunol; 2011; 21(4):325-6. PubMed ID: 21721386
[No Abstract] [Full Text] [Related]
10. Delayed-type hypersensitivity to subcutaneous lidocaine with tolerance to articaine: confirmation by in vivo and in vitro tests.
Bircher AJ; Messmer SL; Surber C; Rufli T
Contact Dermatitis; 1996 Jun; 34(6):387-9. PubMed ID: 8879922
[TBL] [Abstract][Full Text] [Related]
11. Allergic contact dermatitis caused by sodium metabisulfite: a challenging allergen: a case series and literature review.
García-Gavín J; Parente J; Goossens A
Contact Dermatitis; 2012 Nov; 67(5):260-9. PubMed ID: 23039002
[TBL] [Abstract][Full Text] [Related]
12. A dilemma: How does one treat anaphylaxis in the sulfite allergic patient since epinephrine contains sodium metabisulfite?
Roth JV; Shields A
Anesth Analg; 2004 May; 98(5):1499; author reply 1500. PubMed ID: 15105239
[No Abstract] [Full Text] [Related]
13. Systemic allergic dermatitis caused by sodium metabisulfite in rectal enemas.
Borges AS; Valejo Coelho MM; Fernandes C; Brasileiro A; Gonçalo M
Contact Dermatitis; 2018 Jun; 78(6):429-430. PubMed ID: 29446100
[No Abstract] [Full Text] [Related]
14. [Subcutaneous continuous apomorphine infusion: treatment initiation and follow up].
Grandas FJ; Sesar-Ignacio Á
Rev Neurol; 2012; 55 Suppl 1():S21-4. PubMed ID: 23169229
[TBL] [Abstract][Full Text] [Related]
15. [Diagnostic value of the sulfite skin test].
Gay G; Sabbah A; Drouet M
Allerg Immunol (Paris); 1994 Apr; 26(4):139-40. PubMed ID: 8031458
[TBL] [Abstract][Full Text] [Related]
16. Ultrasound treatment of cutaneous side-effects of infused apomorphine: a randomized controlled pilot study.
Poltawski L; Edwards H; Todd A; Watson T; Lees A; James CA
Mov Disord; 2009 Jan; 24(1):115-8. PubMed ID: 19006068
[TBL] [Abstract][Full Text] [Related]
17. Active sensitization to sodium metabisulfite in hydrocortisone cream.
Heshmati S; Maibach HI
Contact Dermatitis; 1999 Sep; 41(3):166-7. PubMed ID: 10475522
[No Abstract] [Full Text] [Related]
18. Delayed hypersensitivity drug reactions diagnosed by patch testing.
Calkin JM; Maibach HI
Contact Dermatitis; 1993 Nov; 29(5):223-33. PubMed ID: 8112060
[TBL] [Abstract][Full Text] [Related]
19. Burning mouth syndrome: hypersensitivity to sodium metabisulfite.
Levanti C; Ricciardi L; Isola S; Cilia M; Guarneri F; Purello D'Ambrosio F
Acta Derm Venereol; 1996 Mar; 76(2):158-9. PubMed ID: 8740278
[No Abstract] [Full Text] [Related]
20. Levodopa-induced dyskinesias and continuous subcutaneous infusions of apomorphine: results of a two-year, prospective follow-up.
Kanovský P; Kubová D; Bareš M; Hortová H; Streitová H; Rektor I; Znojil V
Mov Disord; 2002 Jan; 17(1):188-91. PubMed ID: 11835461
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
